The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...
MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage ...
American sedan can make mincemeat of some of the 90s supercars that it had no right going up against - it is a true sleeper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback